These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 3072558)

  • 61. Lupus nephritis: efficacy of monthly pulse therapy with intravenous methylprednisolone.
    Harisdangkul V; Rockhold L; Myers A
    South Med J; 1989 Mar; 82(3):321-7. PubMed ID: 2646729
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Suppression of plasma hydrocortisone levels. A poor estimate of rectal absorption of glucocorticoids.
    Carg DC; Weidler DJ; Sakmar E; Albert KS; Wagner JG
    Pharmacology; 1980; 21(1):38-42. PubMed ID: 7403254
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Rapid methylprednisolone clearance in a patient with cystic fibrosis.
    Green CG; Kraus CK; Lemanske RF; Farrell PM; Jusko WJ
    Drug Intell Clin Pharm; 1988 Nov; 22(11):876-8. PubMed ID: 3234253
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Inhibition of antigen-induced bronchoconstriction by methylprednisolone succinate.
    Delehunt JC; Yerger L; Ahmed T; Abraham WM
    J Allergy Clin Immunol; 1984 Apr; 73(4):479-83. PubMed ID: 6368648
    [TBL] [Abstract][Full Text] [Related]  

  • 65. CD4+ and CD8+ lymphocyte and cortisol response patterns in elderly and young males after methylprednisolone exposure.
    Tornatore KM; Venuto RC; Logue G; Davis PJ
    J Med; 1998; 29(3-4):159-83. PubMed ID: 9865456
    [TBL] [Abstract][Full Text] [Related]  

  • 66. ["Pulse" methylprednisolone therapy in children with idiopathic thrombocytopenic purpura].
    Ohya M; Kishida K; Nakamura E; Fujimoto S; Sasaki M; Taketomi A; Shirakawa M
    Rinsho Ketsueki; 1985 Oct; 26(10):1600-7. PubMed ID: 3912528
    [No Abstract]   [Full Text] [Related]  

  • 67. Bovine plasma and synovial fluid kinetics of methylprednisolone and methylprednisolone acetate after intra-articular administration of methylprednisolone acetate.
    Toutain PL; Alvinerie M; Fayolle P; Ruckebusch Y
    J Pharmacol Exp Ther; 1986 Mar; 236(3):794-802. PubMed ID: 3950871
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Effects of a single large dose of methylprednisolone sodium succinate on experimental posttraumatic spinal cord ischemia. Dose-response and time-action analysis.
    Hall ED; Wolf DL; Braughler JM
    J Neurosurg; 1984 Jul; 61(1):124-30. PubMed ID: 6374068
    [TBL] [Abstract][Full Text] [Related]  

  • 69. A dermatitis-eosinophilia syndrome. Treatment with methylprednisolone pulse therapy.
    Dahl MV; Swanson DL; Jacob HS
    Arch Dermatol; 1984 Dec; 120(12):1595-7. PubMed ID: 6095766
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Initial rate studies of hydrolysis and acyl migration in methylprednisolone 21-hemisuccinate and 17-hemisuccinate.
    Anderson BD; Taphouse V
    J Pharm Sci; 1981 Feb; 70(2):181-6. PubMed ID: 7009782
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Thin-layer chromatography studies on the metabolism of prednisolone-Na-hemisuccinate and 6-alpha-methylprednisolone-Na-hemisuccinate].
    FUNCK FW; ZICHA L
    Med Exp Int J Exp Med; 1962; 7():1-7. PubMed ID: 13960280
    [No Abstract]   [Full Text] [Related]  

  • 72. Methylprednisolone pharmacokinetics and pharmacodynamics in chronic renal failure.
    Jusko WJ; Milad MA; Ludwig EA; Lew KH; Kohli RK
    Clin Nephrol; 1995 Jan; 43 Suppl 1():S16-9. PubMed ID: 7781199
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Dextran-methylprednisolone succinate as a prodrug of methylprednisolone: dose-dependent pharmacokinetics in rats.
    Zhang X; Mehvar R
    Int J Pharm; 2001 Oct; 229(1-2):173-82. PubMed ID: 11604270
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Pharmacokinetics of methylprednisolone acetate after intra-articular administration and its effect on endogenous hydrocortisone and cortisone secretion in horses.
    Soma LR; Uboh CE; Luo Y; Guan F; Moate PJ; Boston RC
    Am J Vet Res; 2006 Apr; 67(4):654-62. PubMed ID: 16579759
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Intravenous methylprednisolone in adults in status asthmaticus. Comparison of two dosages.
    Tanaka RM; Santiago SM; Kuhn GJ; Williams RE; Klaustermeyer WB
    Chest; 1982 Oct; 82(4):438-40. PubMed ID: 6749443
    [No Abstract]   [Full Text] [Related]  

  • 76. Effect of itraconazole on the pharmacokinetics of prednisolone and methylprednisolone and cortisol secretion in healthy subjects.
    Lebrun-Vignes B; Archer VC; Diquet B; Levron JC; Chosidow O; Puech AJ; Warot D
    Br J Clin Pharmacol; 2001 May; 51(5):443-50. PubMed ID: 11422002
    [TBL] [Abstract][Full Text] [Related]  

  • 77. High dose intravenous methyl prednisolone (pulse therapy) in the treatment of rheumatoid disease.
    Williams IA; Baylis EM; English J
    Scand J Rheumatol; 1981; 10(2):153-5. PubMed ID: 7017916
    [No Abstract]   [Full Text] [Related]  

  • 78. Methylprednisolone disposition in rabbits. Analysis, prodrug conversion, reversible metabolism, and comparison with man.
    Ebling WF; Szefler SJ; Jusko WJ
    Drug Metab Dispos; 1985; 13(3):296-304. PubMed ID: 2861987
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Plasma, salivary and urinary cortisol levels following physiological and stress doses of hydrocortisone in normal volunteers.
    Jung C; Greco S; Nguyen HH; Ho JT; Lewis JG; Torpy DJ; Inder WJ
    BMC Endocr Disord; 2014 Nov; 14():91. PubMed ID: 25425285
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Influence of intravenous methylprednisolone pulse treatment on the disposition of ciclosporin and hepatic CYP3A activity in rats.
    Konishi H; Sumi M; Shibata N; Takada K; Minouchi T; Yamaji A
    J Pharm Pharmacol; 2004 Apr; 56(4):477-83. PubMed ID: 15099443
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.